ArticleScience advances2022
An ultralong-acting tenofovir ProTide nanoformulation achieves monthslong HBV suppression.
Srijanee Das et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
7 papers cite it
this papercites it
ArticleScience advances2022
Srijanee Das et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.